An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

• Status: Completed
• Trial end date: 2016-10-12
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®) as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All treatment decisions lie with the physician.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Prescribed BOTOX® for the prophylaxis of headaches.

Exclusion Criteria:

• Received treatment with any botulinum toxin Type A serotype in the last 26 weeks

• Current participation in Allergan's Botox Chronic Migraine Post-Authorisation Safety Study (protocol 191622-110).